PTAFR and familial pancreatic carcinoma: Our first studies using PAF-R-expressing PANC-1 and -deficient Hs766T pancreatic cancer cells demonstrated that exposure of gemcitabine, similar to a known PAF-R agonist, CPAF, induces the release of MVPs in a PAF-R-dependent manner.